Most of the drugs from this class marketed to date are intended to induce sleep, and are prescribed for people suffering insomnia, however some newer compounds produce anxiolytic effects with relatively little sedation, and are being developed for use as non-sedating anti-anxiety drugs.
As they are not chemically related to the benzodiazepines despite their similar effect, such drugs—as well as the imidazopyridines and cyclopyrrones—are sometimes grouped together and referred to as "nonbenzodiazepines".
Researchers Submit Patent Application, "Immunodetection and Quantification of Pyrazolopyrimidine Sedatives", for Approval
Sep 08, 2012; By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that...
US Patent Issued to Korea Institute of Science and Technology on July 31 for "Pyrazolopyrimidine Derivatives Having Biological Activity on Serotonin Receptor 5-HT2C" (South Korean Inventors)
Aug 07, 2012; ALEXANDRIA, Va., Aug. 7 -- United States Patent no. 8,232,279, issued on July 31, was assigned to Korea Institute of Science and...